3,136 件 ・ 関連度順
概要と使いどころ
Orchestrate iOS screenshot automation with xcodebuild/simctl for build-run, AXe for UI actions, JSON settings and plan files, Koubou-based framing (`asc screenshots frame`), and screenshot upload (`asc screenshots upload`). Use when users ask for automated screenshot capture, AXe-driven simulator flows, frame composition, or screenshot-to-upload pipelines.
日本語の概要は準備中です。原文の説明を表示しています。
New App Intents APIs and behaviors for iOS 27 and macOS 27: SnippetIntent, LongRunningIntent, execution modes, and interactive snippets.
日本語の概要は準備中です。原文の説明を表示しています。
New SwiftUI features and patterns for iOS 27 and macOS 27: @State macro, reorderable containers, AsyncImage caching, and new swipe actions.
日本語の概要は準備中です。原文の説明を表示しています。
Implements push notifications across iOS, Android, and web using Firebase Cloud Messaging and native services. Use when adding notification capabilities, handling background messages, or setting up notification channels.
日本語の概要は準備中です。原文の説明を表示しています。
Mobile app debugging for iOS, Android, cross-platform frameworks. Use for crashes, memory leaks, performance issues, network problems, or encountering Xcode instruments, Android Profiler, React Native debugger, native bridge errors.
日本語の概要は準備中です。原文の説明を表示しています。
Publishes mobile applications to iOS App Store and Google Play with code signing, versioning, and CI/CD automation. Use when preparing app releases, configuring signing certificates, or setting up automated deployment pipelines.
日本語の概要は準備中です。原文の説明を表示しています。
Run the weak-agent adversarial test harness against docx-cli. Spawns weak exercise agents (Haiku by default, Sonnet to probe, or a local agent harness's pre-produced runs) to perform real document tasks over six scenarios — five editing (MNDA form-fill + font fidelity, invoice table-edit/restructure + logo replace, résumé styling, contract redlining + commenting, contract finalize via accept/reject + comment reply/resolve) and one authoring (T. S. Eliot poetry journal: multi-column, verse, footnotes, links, figure) — renders every result with Word, has opus judge them against ground-truth rubrics, measures each exercise's tool economy, token cost, wall-clock, and correctness (from transcripts for Claude, the exercise.json ledger for the local harness), and synthesizes a prioritized ergonomics report. Use when the user says 'adversarial review', 'test docx-cli with weak agents', 'run the haiku harness', 'weak agent test', or wants to re-run yesterday's adversarial process.
日本語の概要は準備中です。原文の説明を表示しています。
Build sales battlecards with feature comparisons, objection handling scripts, positioning statements, and win themes for competitive deal scenarios. Use when the user requests competitive battlecard creation or provides relevant inputs for this workflow.
日本語の概要は準備中です。原文の説明を表示しています。
当系统提示面向移动端（手机、平板）场景时调用。适用于 iOS/Android 应用内 AI 助手、移动端聊天界面、响应式输出的系统提示设计。不适用于桌面端优先的场景，不适用于移动端 UI 开发（非提示层），不适用于语音场景（语音场景使用 voice-optimization）。
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Glycobiologist. Use when a task calls for Glycobiologist judgment. Reasons from N-/O-glycan biosynthesis, O-GlcNAc cycling (OGT/OGA), LC-MS glycomics, exoglycosidase sequencing, and lectin microarrays; uses GlyTouCan/SNFG/MIRAGE, pGlyco/GlycoWorkbench, and treats PNGase F limits, isomer collapse, and ER-stress high-mannose as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Industrial Ecologist. Use when a task calls for Industrial Ecologist judgment. Reasons from mass balance closure, in-use stocks, and system boundaries through STAN (ÖNorm S 2096), dynamic MFA with Weibull lifetime distributions, EEIO tables (EXIOBASE, USEEIO) and pedigree-scored Monte Carlo while treating non-closing residuals, re-export trade hubs, downcounted informal-sector leakage, and Kalundborg-copied symbiosis without quality-spec match as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Herpetologist. Use when a task calls for Herpetologist judgment. Reasons from detectability-limited sampling and ectotherm phenology through VES, pitfall/drift-fence and cover-board arrays, NAAMP call surveys, Program MARK CJS, unmarked/occuTTD occupancy, and Bd/Bsal MW113 qPCR biosecurity; uses AmphibiaWeb, Reptile Database, SSAR 9th ed./CNAH names, Amphibian Disease Portal, GBIF/CoordinateCleaner, and ARRIVE 2.0 while treating weather bias, pitfall selectivity, and pathogen cross-contamination as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Climate Risk Analyst. Use when a task calls for Climate Risk Analyst judgment. Reasons from TCFD/IFRS S2 four-pillar disclosure, NGFS Phase V orderly/disorderly/hot-house scenarios, hazard–exposure–vulnerability and RMS/AIR/CLIMADA cat economics, transition carbon-price and stranded-asset pathways, and PCAF financed emissions while treating exposure geocoding quality, Kotz damage-function retraction, and scenario-not-forecast misuse as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Astrobiologist. Use when a task calls for Astrobiologist judgment. Reasons from habitability, redox disequilibrium, and Bayesian biosignature frameworks through Mars (Perseverance, Viking perchlorate lessons), Europa Clipper ocean worlds, agnostic signatures and the Ladder of Life Detection, while treating abiotic mimics, preservation, and LUCA phylogenomics as constraints—not templates—for extraterrestrial life.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Aquaculture Scientist. Use when a task calls for Aquaculture Scientist judgment. Reasons from FCR, dissolved oxygen and ammonia thresholds, hatchery biosecurity, and stock genetics while treating off-flavor, disease outbreak, and escape risk as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Weekly product-level commercial tracking — TRx/NRx with current/4-wk/12-wk share and YoY, launch curves overlaid with same-class analogs plus a consensus-implied trajectory, LOE/biosimilar erosion series, GTN/net-price stress brackets, and per-row data-caveat discipline. Use to track any launched drug, biologic, device, or vaccine against its class and consensus.
日本語の概要は準備中です。原文の説明を表示しています。
CDER-track catalyst analysis for medicines: PDUFA target dates, AdCom votes, sNDA/sBLA label expansions, biosimilar interchangeability and 180-day exclusivity, Orange Book state, and CRL remediation timelines — enumerated, verified, and sized per event for any biotech/pharma ticker or watchlist.
日本語の概要は準備中です。原文の説明を表示しています。
Institutional-grade equity research skills for AI agents. 80 Claude-type skills across 14 verticals (equity-research-core, models-and-pitches, bio-pharm, scenarios, quantitative-analysis, idea-generation, options-derivatives, business-intelligence, industry-analysis, macro-strategy, portfolio-strategy, technical-analysis, risk-and-psychology, trading-as-business) powered by agentii.ai's agent-use-ready SEC filing data plane — SEC filings and 15K+ earnings call transcripts, 15.99M XBRL facts, and company profiles for 1,146+ US-public-equity tickers. Features the three-layer retrieval protocol (Document Discovery → Page Map → Deep Read, with deep-outline escalation) — measured, not asserted: 97.5% saved against a sequential read, and the page map itself is 10.0% of one (spec 062 T030, 2026-09-23) — server-side parallel multi-period search via search_cross_period, a full Excel/PPT generation pipeline with 3-tier office backend support, and the spec-046 governance layer (constitution, thesis and single-skill modes, mechanical gates, and a template-owned disclaimer on generated reports).
日本語の概要は準備中です。原文の説明を表示しています。
Testing workflow skill for finding high-value test candidates, writing focused tests, generating realistic workloads, reviewing test value, and diagnosing test-suite health. Use for prompts about what to test next, adding or improving tests, reviewing whether a test is worth keeping, low-signal or flaky tests, workload scenarios, or test-suite trust. Do not use for general QA discussion unless the user wants a concrete testing workflow or artifact.
日本語の概要は準備中です。原文の説明を表示しています。
Analyzes cfDNA fragment size distributions and fragmentomics features using FinaleToolkit or Griffin. Extracts nucleosome positioning patterns, fragment ratios, and DELFI-style fragmentation profiles for cancer detection. Use when leveraging fragment patterns for tumor detection or tissue-of-origin analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Computes and interprets treatment effect measures (OR, RR, RD, HR, NNT) with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen, MOVER, profile likelihood, Bender NNT) and reports marginal vs conditional estimands per FDA 2023 covariate adjustment guidance. Use when reporting treatment effects in confirmatory trials, comparing effect sizes across studies, or constructing forest plots.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive quality control for CLIP-seq libraries (eCLIP, iCLIP, iCLIP2, PAR-CLIP) covering library complexity (preseq), FRiP, IDR replicate reproducibility, read-distribution metagene, SMInput vs IgG control rationale, rRNA / snoRNA contamination, fragment-length distribution, and ENCODE-compliance thresholds. Use when assessing whether a CLIP library passed, deciding lenient vs stringent peak thresholds, comparing replicates with IDR rescue and self-consistency ratios, or distinguishing failed IP from over-amplified library.
日本語の概要は準備中です。原文の説明を表示しています。
Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.
日本語の概要は準備中です。原文の説明を表示しています。
Reads, validates, and prepares CDISC SDTM and ADaM clinical trial data for analysis. Covers SDTM domain joins (DM, AE, EX, VS, LB, DS), ADaM architecture (ADSL, BDS, OCCDS, ADTTE) with traceability, treatment-emergent AE conventions, baseline derivation, SUPPQUAL/NSV handling, Define-XML 2.1, and Pinnacle 21 / CORE validation. Use when working with clinical trial datasets in CDISC SDTM/ADaM format, preparing analysis-ready data, or validating for regulatory submission.
日本語の概要は準備中です。原文の説明を表示しています。